Moberg Pharma AB (publ) (MBGPF)

Moberg Pharma AB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	44	43	42	22	26	17
Market Cap Growth	-37.78%	1.53%	93.23%	-16.39%	50.10%	-40.40%
Enterprise Value	16	15	33	8	14	15
Last Close Price	0.95	0.86	-	-	-	1.65
PE Ratio	-	-	-	-	31.57	24.40
PS Ratio	34.19	48.40	-	1101.38	-	4.25
PB Ratio	0.64	0.69	0.70	0.43	0.55	0.36
P/TBV Ratio	0.64	0.69	0.70	0.43	0.55	0.37
EV/Sales Ratio	11.95	17.28	-	421.77	-	3.76
EV/EBITDA Ratio	-	-	-	-	-	12.82
EV/EBIT Ratio	-	-	-	-	-	12.89
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	-	-	-	-	-	0.60
Asset Turnover	0.02	0.02	-	0	-	-
Inventory Turnover	0.72	0.61	-	-	-	-
Quick Ratio	18.06	17.59	2.99	4.74	6.68	0.27
Current Ratio	18.45	17.95	3.38	4.77	6.74	2.08
Return on Equity (ROE)	-38.96%	-39.32%	-3.69%	-3.25%	-3.91%	-
Return on Assets (ROA)	-30.07%	-30.29%	-2.91%	-2.53%	-2.65%	-
Return on Capital (ROIC)	-30.91%	-31.09%	-3.02%	-2.62%	-2.93%	-
Return on Capital Employed (ROCE)	-	-	-	-	-	2.50%
Earnings Yield	-57.17%	-53.72%	-4.96%	-6.89%	3.17%	4.10%
FCF Yield	-	-3.47%	-7.81%	-7.39%	-6.47%	-7.27%
Buyback Yield / Dilution	-108.43%	-138.46%	-109.19%	-76.28%	-127.45%	-0.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.